Cargando…
A Bioactive Compound from Sanguisorba officinalis L. Inhibits Cell Proliferation and Induces Cell Death in 5-Fluorouracil-Sensitive/Resistant Colorectal Cancer Cells
Colorectal cancer (CRC) is one of the most common cancer in the world. The first line chemotherapeutic agent, 5-fluorouracil (5-FU), plays a predominant role in the clinical treatment of CRC. However, with the wide use of 5-FU, more and more CRC patients have been obtaining drug resistance to 5-FU,...
Autores principales: | Zhang, Weijia, Peng, Chang, Shen, Xue, Yuan, Yuemei, Zhang, Wei, Yang, Chunjuan, Yao, Meicun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270258/ https://www.ncbi.nlm.nih.gov/pubmed/34202548 http://dx.doi.org/10.3390/molecules26133843 |
Ejemplares similares
-
Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways
por: Zhang, Weijia, et al.
Publicado: (2023) -
Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer
por: Zhang, Weijia, et al.
Publicado: (2022) -
In vitro anti‐bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection
por: Shen, Xue, et al.
Publicado: (2021) -
Bioactivity-guided isolation and identification of anti-adipogenic compounds from Sanguisorba officinalis
por: Im, Sun Hyuk, et al.
Publicado: (2017) -
Simultaneous Determination and Pharmacokinetics Study of Six Triterpenes in Rat Plasma by UHPLC-MS/MS after Oral Administration of Sanguisorba officinalis L. Extract
por: Wu, Chengcui, et al.
Publicado: (2018)